Deerfield Management Company, L.P. (Series C) Kura Oncology, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 5,411,571 shares of KURA stock, worth $48.8 Million. This represents 1.97% of its overall portfolio holdings.
Number of Shares
5,411,571
Previous 5,411,571
-0.0%
Holding current value
$48.8 Million
Previous $111 Million
5.1%
% of portfolio
1.97%
Previous 2.34%
Shares
11 transactions
Others Institutions Holding KURA
# of Institutions
185Shares Held
81.8MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$69 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$62.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$52.3 Million4.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$39 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$37.9 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $603M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...